NCT00245258View on ClinicalTrials.gov

Study to Evaluate Viagra's Ability to Provide a Better Sexual Experience Through Quality Erections and Satisfaction

PHASE4CompletedINTERVENTIONAL
Enrollment

312

Participants

Timeline

Start Date

November 30, 2005

Study Completion Date

September 30, 2006

Conditions
Impotence
Interventions
DRUG

Sildenafil Citrate

Trial Locations (19)

28046

Pfizer Investigational Site, Madrid

39008

Pfizer Investigational Site, Santander

41014

Pfizer Investigational Site, Seville

105425

Pfizer Investigational Site, Moscow

117036

Pfizer Investigational Site, Moscow

125101

Pfizer Investigational Site, Moscow

344022

Pfizer Investigational Site, Rostov-on-Don

Unknown

Pfizer Investigational Site, Saint Petersburg

602-739

Pfizer Investigational Site, Pusan

110-744

Pfizer Investigational Site, Seoul

135-710

Pfizer Investigational Site, Seoul

136-705

Pfizer Investigational Site, Seoul

138-736

Pfizer Investigational Site, Seoul

158-710

Pfizer Investigational Site, Seoul

08035

Pfizer Investigational Site, Barcelona

374 35

Pfizer Investigational Site, Karlshamn

205 02

Pfizer Investigational Site, Malmo

541 31

Pfizer Investigational Site, Skövde

171 76

Pfizer Investigational Site, Stockholm

All Listed Sponsors
lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT00245258 - Study to Evaluate Viagra's Ability to Provide a Better Sexual Experience Through Quality Erections and Satisfaction | Biotech Hunter | Biotech Hunter